Immune Cell Infiltration and the Expression of PD-1 and PD-L1 in Primary PDGFRA-Mutant Gastrointestinal Stromal Tumors

被引：0
|
作者：
Xiangfei Sun
Jianyi Sun
Wei Yuan
Xiaodong Gao
Min Fu
Anwei Xue
He Li
Ping Shu
Yong Fang
Yingyong Hou
Kuntang Shen
Yihong Sun
Jing Qin
Xinyu Qin
机构：
[1] Zhongshan Hospital,Department of General Surgery
[2] Fudan University School of Medicine,Department of Pathology
[3] Zhongshan Hospital,undefined
[4] Fudan University School of Medicine,undefined
来源：
Journal of Gastrointestinal Surgery | 2021年 / 25卷
关键词：
Gastrointestinal stromal tumors; Immunotherapy; Immune infiltrate; Programmed cell death-ligand 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2091 / 2100
页数：9
相关论文
共 50 条
  • [41] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [42] Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
    Patera, Andriani C.
    Drewry, Anne M.
    Chang, Katherine
    Beiter, Evan R.
    Osborne, Dale
    Hotchkiss, Richard S.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (06) : 1239 - 1254
  • [43] Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases
    Manson, Quirine F.
    Schrijver, Willemijne A. M. E.
    ter Hoeve, Natalie D.
    Moelans, Cathy B.
    van Diest, Paul J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (01) : 29 - 37
  • [44] Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival
    Liu, Jingwei
    Li, Hao
    Sun, Liping
    Yuan, Yuan
    Xing, Chengzhong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [45] PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
    Joseph, Richard W.
    Millis, Sherri Z.
    Carballido, Estrella M.
    Bryant, David
    Gatalica, Zoran
    Reddy, Sandeep
    Bryce, Alan H.
    Vogelzang, Nicholas J.
    Stanton, Melissa L.
    Castle, Erik P.
    Ho, Thai H.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) : 1303 - 1307
  • [46] Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas
    Hashimoto, Kazuhiko
    Nishimura, Shunji
    Ito, Tomohiko
    Akagi, Masao
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2021, 65 (03):
  • [47] INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Baquerizo, Angeles
    Vavinskaya, Vera
    Rojas, Angela
    Mhoyan, Anna
    Romero-Gomez, Manuel
    Sher, Linda
    Madani, Bahar
    Fisher, Jonathan
    Schaffer, Randolph
    Frenette, Catherine T.
    Marsh, Christopher
    HEPATOLOGY, 2019, 70 : 206A - 206A
  • [48] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [49] PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
    Huang, Changsheng
    Ren, Shengxiang
    Chen, Yaqi
    Liu, Anyi
    Wu, Qi
    Jiang, Tao
    Lv, Panjing
    Song, Da
    Hu, Fuqing
    Lan, Jingqing
    Sun, Li
    Zheng, Xue
    Luo, Xuelai
    Chu, Qian
    Jia, Keyi
    Li, Yan
    Wang, Jun
    Zou, Caicun
    Hu, Junbo
    Wang, Guihua
    SCIENCE ADVANCES, 2023, 9 (21)
  • [50] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
12345